Co-Authors
This is a "connection" page, showing publications co-authored by Aakriti Gupta and Mahesh Madhavan.
Connection Strength
0.915
-
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun. 2021 02 26; 12(1):1325.
Score: 0.233
-
Extrapulmonary manifestations of COVID-19. Nat Med. 2020 07; 26(7):1017-1032.
Score: 0.223
-
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 04 27; 325(16):1620-1630.
Score: 0.059
-
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 Jan; 122(1):131-141.
Score: 0.059
-
Post-acute COVID-19 syndrome. Nat Med. 2021 04; 27(4):601-615.
Score: 0.058
-
Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy. Thromb Res. 2021 02; 198:79-82.
Score: 0.057
-
Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19. J Am Heart Assoc. 2021 01 05; 10(1):e018476.
Score: 0.057
-
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19. Eur J Endocrinol. 2020 Nov; 183(5):R133-R147.
Score: 0.057
-
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res. 2020 12; 196:382-394.
Score: 0.057
-
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul; 120(7):1004-1024.
Score: 0.055